[1] |
WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua.
Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
|
[2] |
ZHOU Kun, MA Liang, LI Zhaofeng, CAO Bing, GU Hongwei, LIU Qian.
Usage of Nerve-Calming Chinese Herbal Patent Medicines in a Mental Health Center
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 211-216.
|
[3] |
GUO Yuansheng, ZUO Tiantian, LIU Li'na, WEI Feng, DONG Zhe, LI Jing, JIN Hongyu, MA Shuangcheng.
Twenty-eight elements in Coicis Semen and risk assessment by stir-frying with bran by inductively coupled plasma-mass spectrometry
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1008-1013.
|
[4] |
LU Zhenkai, YANG Dingquan, XIE Zhennian, WANG Lianxin, LI Yuanyuan, WANG Zhifei, CUI Xin, XIE Yanming.
Interpretation and insights from the “Guidelines for Pharmacovigilance of Topical Traditional Chinese Medicines in Clinical Applications”
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1029-1033.
|
[5] |
ZHENG Haiyun, ZHANG Wen, WANG Shaonan, ZHAO Haiyu, DU Shouying.
Anti-fatigue effects and mechanism of ginseng combined with caffeine in rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 863-870.
|
[6] |
CAI Haili, ZHANG Xiaomeng, LIU Yadi, LIU Shujia, GAO Fujun, WANG Yu, ZHANG Bing.
Progress in construction and evaluation of a drug-induced cardiotoxicity model
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 765-770.
|
[7] |
SHI Guanhong, WANG Qi, SUN Hao, CHEN Yanjie, CHU Ziyan, JIANG Ao, TANG Zaixiang, LIU Jingfang.
Safety signal analysis of antidepressants use in fetus and neonate based on US FAERS database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 687-692.
|
[8] |
WANG Chunnan, QIN Shiru, ZHANG Meng, SONG Haibo, LIU Junchang, LI Ge, SUN Feng.
Evaluation of drug safety with multicenter real-world data
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 703-708.
|
[9] |
CAO Ying, ZHOU Huziwei, ZHU Lan, WANG Shengfeng.
Management of compound glycyrrhiza oral solution and recommendations
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 529-534.
|
[10] |
SU Xiaohan, ZENG Jiao, LI Xue, LIU Lixin, HOU Lingmi, LI Jinsui.
Adverse events of abemaciclib in breast cancer patients based on US FAERS database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 580-586.
|
[11] |
SUN Qiyue, GUO Shanshan, ZHAO Ronghua, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing.
Research progress on animal models of allergic rhinitis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 241-245.
|
[12] |
SUN Jing, ZHAO Ronghua, GUO Shanshan, GAO Shuangrong, BAO Lei, GENG Zihan, LI Shuran, SUN Qiyue, XU Zhou, QIN Guangyuan, PAN Yujie, TAN Qiuxia, LONG Zhongyi, HUANG Chenggang, CUI Xiaolan.
Therapeutic effect of aerosol inhalation of BD-77 against mycoplasma pneumoniae infection in mice
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 253-256.
|
[13] |
SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing.
Multiple pharmacological effects of Lingyang Ganmao Oral Liquid
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131.
|
[14] |
ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan.
Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136.
|
[15] |
MA Meiying, ZHAO Xiaopei, ZHANG Mengyao, HU Yilin.
Drug traceability coding system in China
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 167-172.
|